Home

Hűtlenség Annotate csoda mog antibody disease Tanítás Szenátor Kifejezett

Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR  encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease  - ScienceDirect
Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease - ScienceDirect

Clinicoradiological comparative study of Aquaporin-4-IgG seropositive  neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated  disease (MOGAD): A prospective observational study and review of literature  - ScienceDirect
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature - ScienceDirect

Serum level of IL-1β in patients with inflammatory demyelinating disease:  Marked upregulation in the early acute phase of MOG antibody associated  disease (MOGAD) - ScienceDirect
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD) - ScienceDirect

What is MOGAD? | MOG Antibody Disease | SRNA
What is MOGAD? | MOG Antibody Disease | SRNA

Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated  Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS  Disorders?
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?

IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated  Disease: Current Insights into the Disease Pathophysiology, Diagnosis and  Management
IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS  Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody  Positive Neuromyelitis Optica Spectrum Disorder
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder

Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease  justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology &  Neuroinflammation
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology & Neuroinflammation

Neurological update: MOG antibody disease | SpringerLink
Neurological update: MOG antibody disease | SpringerLink

Frontiers | A Fulminant Case of Demyelinating Encephalitis With Extensive  Cortical Involvement Associated With Anti-MOG Antibodies
Frontiers | A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies

MOG Antibody Disease - Practical Neurology
MOG Antibody Disease - Practical Neurology

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease:  practical considerations | Practical Neurology
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology

Spectrum of MOG antibody-associated disorders. | Download Scientific Diagram
Spectrum of MOG antibody-associated disorders. | Download Scientific Diagram

Clinical decision making in MOG antibody-associated disease - The Lancet  Neurology
Clinical decision making in MOG antibody-associated disease - The Lancet Neurology

MOGAD Awareness Month (1) | spinal cord, inflammation | We begin MOG  Antibody Disease Awareness Month by giving a short description and  explanation of MOG antibody disease. MOG antibody disease, or MOGAD, is  a... | By Siegel Rare Neuroimmune ...
MOGAD Awareness Month (1) | spinal cord, inflammation | We begin MOG Antibody Disease Awareness Month by giving a short description and explanation of MOG antibody disease. MOG antibody disease, or MOGAD, is a... | By Siegel Rare Neuroimmune ...

Neuromyelitis Optica (NMO): What It Is, Symptoms & Treatment
Neuromyelitis Optica (NMO): What It Is, Symptoms & Treatment

MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19 -  The Lancet Neurology
MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19 - The Lancet Neurology

MOG antibody disease: A review of MOG antibody seropositive neuromyelitis  optica spectrum disorder - ScienceDirect
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - ScienceDirect

Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical  spectrum, diagnostic evaluation, and treatment options
Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options

Frontiers | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis:  Lessons Learned From Neuromyelitis Optica Spectrum Disorder
Frontiers | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder

Anti-MOG antibodies are present in a subgroup of patients with a  neuromyelitis optica phenotype | Journal of Neuroinflammation | Full Text
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype | Journal of Neuroinflammation | Full Text

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Myelitis Presenting  with Headache | Canadian Journal of Neurological Sciences | Cambridge Core
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Myelitis Presenting with Headache | Canadian Journal of Neurological Sciences | Cambridge Core

MOG Antibodies Tied to More Pediatric Conditions | MedPage Today
MOG Antibodies Tied to More Pediatric Conditions | MedPage Today

IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment  Approaches for NMOSD and MOGAD
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD